Insulin Infusion Systems

Subscribe to Selected New Research on Insulin Infusion Systems

73 relevant articles (1 outcomes, 2 trials/studies) found for this Therapy

Description: Portable or implantable devices for infusion of insulin. Includes open-loop systems which may be patient-operated or controlled by a pre-set program and are designed for constant delivery of small quantities of insulin, increased during food ingestion, and closed-loop systems which deliver quantities of insulin automatically based on an electronic glucose sensor.

Also Known As:

Implantable Programmable Insulin Pump; Insulin Pump, Programmable Implantable; Pump, Programmable Implantable Insulin; Artificial Endocrine Pancreas; Artificial beta Cell; Artificial beta Cells; Cell, Artificial beta; Cells, Artificial beta; Endocrine Pancreas, Artificial; Infusion System, Insulin; Infusion Systems, Insulin; Insulin Infusion System; System, Insulin Infusion; Systems, Insulin Infusion; beta Cells, Artificial; Pancreas, Artificial Endocrine; Programmable Implantable Insulin Pump; beta Cell, Artificial

Relationship Network

Therapy Context: Research Results

Therapeutics: 5229

Drug Therapy: 116907

Drug Delivery Systems

Insulin Infusion Systems: 73

Equipment and Supplies

Infusion Pumps: 440

Insulin Infusion Systems: 73

Surgical Equipment: 28

Artificial Organs: 61

Infusion Pumps: 440

Insulin Infusion Systems: 73

Related Diseases

1.	Ketosis 04/01/1978 - "Remission of diabetes was attempted in 12 recent acute onset ketosis-prone juvenile diabetes after short term (5 +/- 1 days) but excellent blood glucose control by the external artificial beta-cell" 01/01/1979 - "Application of the artificial endocrine pancreas in 12 patients undergoing total duodenopancreatectomy and 3 diabetics in whom different operations were performed proved to be safe for the patients with respect to blood glucose control and prevention of ketosis" Order ALL the reference details at left...
2.	Body Weight (Weight, Body) 02/01/1981 - "There was no correlation with age, body weight, duration of diabetes, nor with the nature and order of administration of the CHO load; 5.1 +/- 1.6 to 13.7 +/- 2.1 units of insulin were needed for a period of 94 +/- 11 to 132 +/- 11 min. It is suggested that some of the data obtained in this study might be useful in the programming of an open-loop insulin infusion system." 01/01/1980 - "An implantable artificial endocrine pancreas consisting of a coiled single acrylic copolymer capillary surrounded by a rat islets (1000/kg body weight) was implanted in 10 streptozotocin-alloxan diabetic dogs" 07/01/1984 - "The short-term effect of the glucose-controlled insulin infusion system (GCIIS) Biostator on metabolic and hormonal responses to a 2 h glucose infusion (0.33 g/kg body weight glucose i.v. followed by an infusion of 12 mg/kg/min) was studied in 8 insulin-dependent diabetic patients (IDDM)" Order ALL the reference details at left...
3.	Acquired Immunodeficiency Syndrome (AIDS) 01/01/1982 - "Thus, deriving a patient's daily insulin dose from the insulin production rate of healthy man may add an additional experimental protocol which aids in making general calculations of a necessary insulin dose instead of using trial and error or a closed-loop insulin infusion system." Order ALL the reference details at left...
4.	Diabetes Mellitus 10/01/1994 - "The bedside-type artificial endocrine pancreas has been proven to be useful not only as a therapeutic tool for diabetes mellitus but also as an elegant research tool for investigating the pathophysiology of the disease" 05/01/1987 - "The effect of restoration of euglycemia with the artificial beta-cell (Biostator GCIIS) on triglyceride metabolism was studied in seven normolipidemic patients with type I diabetes mellitus" 05/01/1986 - "New implantable, variable-rate, intravenous insulin infusion systems offer the possibility of increased dietary flexibility in the treatment of diabetes mellitus" 09/01/1985 - "In a patient with phaeochromocytoma who presented with unstable diabetes mellitus, an artificial endocrine pancreas was used intraoperatively" 01/01/1984 - "The development of wearable-type artificial endocrine pancreas and its usefulness in glycaemic control of human diabetes mellitus." Order ALL the reference details at left...
5.	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 01/01/1997 - "OBJECTIVE: To examine the long-term benefits and risks of treatment of IDDM with an implantable programmable insulin pump" 01/01/1993 - "Restoration of fuel homeostasis in IDDM patients during pregnancy by an open-loop insulin infusion system." 01/01/1988 - "Experience with using automated insulin infusion systems in diabetes mellitus type 1]" 04/01/1983 - "Use of the intravenous programmed insulin infusion system in patients with type 1 diabetes mellitus]" 04/01/2004 - "Continuous glucose monitoring is becoming increasingly more widespread for the routine care of people with type 1 diabetes mellitus and may eventually be used in closed-loop artificial beta-cell systems" Order ALL the reference details at left...

Related Drugs and Biologics

1.	Blood Glucose (Blood Sugar)
2.	Insulin (Novolin)
3.	CAV protocol (CHO)
4.	Glucose (Dextrose)
5.	Glucagon (Glukagon)
6.	Somatostatin (Somatotropin Release-Inhibiting Factor)
7.	Proinsulin
8.	C-Peptide
9.	Arginine (L-Arginine)
10.	Lactic Acid

Related Therapies and Procedures

1.	Insulin Infusion Systems
2.	Artificial Pancreas
3.	Pancreaticoduodenectomy
4.	Infusion Pumps (Infusion Pump)
5.	Anesthesia

Best Treatments:
Research Summary Report
on Ketosis

*WARNING* This specific disease subtype has a relatively small number of significant evidence outcomes. You may proceed to order anyway, or go back to the search field and enter a more general type of the target illness. Once your report has been ordered, however, we can't refund the purchase.

CureHunter Patient-Physician Summary Reports collect in one document all the medications ever reported in the US National Library of Medicine—1949 to the present—to be effective against your target disease. CureHunter research summary reports will vary in length from 25 to 250 pages. Analytic charts allow you and your physicians to see at a glance your medication options—including new, promising, off-label and experimental all rated for clinical efficacy.

Free Updates for 1 Year
All 41 Outcomes
Top 200 Key Drugs and Biologics
Top 27 Key Therapies and Procedures
Detailed History Charts
Full Research Reference Details
Sample PDF Report on Psoriasis >>

Price:

$24.00 & Delivery via PDF download
updates for 1 year

Research Interface

Rapidly retrieve summaries of all the evidence for any disease in seconds. Save hours of search and analysis time. CureHunter is unlike any "search engine" you have ever used. Where standard "search engines" produce lists of links, CureHunter quantifies evidence, extracts it from the literature and calculates a result you can use to immediately facilitate evidence based decision making in Real Clinical Time.

Unlimited Disease, Drug and Therapy Search
2 clicks from Disease to Drug to Evidence
Trial References
All the Positive Outcomes
Detailed Relationship Timeline Charts
Full Article Reference Details
Includes Mobile Interface Subscription
One-click to FDA Products/Patents
Request Institution License Details >>

Price:

$490.00 access via web interface
1 year subscription

Proceed to Checkout >>

Mobile Interface

Retrieve summaries of all the evidence for any disease from your Mobile Phone or PDA. Accelerate decision making in the field. Speed up your study of new drug and disease domains. Refresh your knowledge on the road.

Access from any web enabled PDA or Phone
Trial references
All the Positive Outcomes
Drug and Therapy searches
Full Article Reference Details
Try Mobile Interface >>

Price:

$45.00 access via "curehunter.com/m"
1 year subscription

Proceed to Checkout >>